{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:34:07Z","timestamp":1792798447186,"version":"4.5.0"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This review aims to explore the pathophysiological mechanisms and emerging therapies for type 2 chronic rhinosinusitis with nasal polyps (CRSwNP), driven primarily by type 2 inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Search methods<\/jats:title>\n                    <jats:p>A comprehensive search of relevant literature was performed in databases including PubMed, Web of Science, and Scopus, using keywords such as \u201cchronic rhinosinusitis with nasal polyps,\u201d \u201ctype 2 inflammation,\u201d \u201cTh2 cells,\u201d \u201cILC2s,\u201d \u201cepithelial barrier dysfunction,\u201d and \u201cbiologics\u201d. The search was limited to articles published from January 2010 to February 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Search results<\/jats:title>\n                    <jats:p>A total of 200 articles were initially retrieved. After screening based on relevance and quality, 163 articles were selected for this review. These included 109 basic research papers, 30 clinical studies, and 24 review articles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Type 2 CRSwNP pathogenesis involves Th2\/ILC2-IL-4\/IL-13 synergy, driving eosinophilic inflammation and tissue remodeling via a self-amplifying loop. Programmed cell death protein 1 and programmed death-ligand 1 dysregulation intensifies Th2 responses. Epithelial barrier defects (via disrupted junctions and ciliary defects) and epithelial\u2013mesenchymal transition facilitate pathogen invasion and stromal changes. M2 macrophages amplify inflammation via CCL-24 and\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      synergy, sustaining biofilm persistence. Targeted biologics\u2014dupilumab (IL-4R\u03b1 inhibitor) reduces polyp burden and restores smell, while mepolizumab (anti-IL-5) and omalizumab (anti-IgE) address specific endotypes. Despite therapeutic advances, biologics require real-world validation for long-term safety and cost-effectiveness.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/falgy.2025.1599797","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:53:22Z","timestamp":1751421202000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["The advance on pathophysiological mechanisms of type 2 chronic rhinosinusitis with nasal polyposis"],"prefix":"10.3389","volume":"6","author":[{"given":"Cheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12016-023-08976-y","article-title":"Diverse endotypes of chronic rhinosinusitis and clinical implications","volume":"65","author":"Xie","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/00034894041130s502","article-title":"Epidemiology and economic impact of rhinosinusitis","volume":"113","author":"Anand","year":"2004","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ACI.0000000000000588","article-title":"Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis","volume":"20","author":"Ryu","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.anl.2023.08.002","article-title":"The current findings in eosinophilic chronic rhinosinusitis","volume":"51","author":"Tsuda","year":"2024","journal-title":"Auris Nasus Larynx"},{"key":"B6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/alr.22234","article-title":"Changes in the clinical and histological characteristics of Chinese chronic rhinosinusitis with nasal polyps over 11 years","volume":"9","author":"Wang","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2500\/ajra.2013.27.3922","article-title":"Inflammatory patterns in upper airway disease in the same geographical area may change over time","volume":"27","author":"Katotomichelakis","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinol J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of chronic rhinosinusitis and nasal polyposis","volume":"12","author":"Schleimer","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12950-016-0121-8","article-title":"Pathogenesis of eosinophilic chronic rhinosinusitis","volume":"13","author":"Shah","year":"2016","journal-title":"J Inflamm (Lond)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-4939-9167-9_6","article-title":"In vitro differentiation of effector CD4+ T helper cell subsets","volume":"1960","author":"Read","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","article-title":"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production","volume":"75","author":"Zhu","year":"2015","journal-title":"Cytokine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3969\/j.issn.1000-484X.2024.01.002","article-title":"Progress on mechanism of type \u2161 immune cells (Th2\/ILC2) in allergic pulmonary inflammation","volume":"40","author":"Zhang","year":"2024","journal-title":"Chin J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","article-title":"Type 2 cytokines: mechanisms and therapeutic strategies","volume":"15","author":"Wynn","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/362245a0","article-title":"Disruption of the murine IL-4 gene blocks Th2 cytokine responses","volume":"362","author":"Kopf","year":"1993","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","article-title":"IL-13 effector functions","volume":"21","author":"Wynn","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fphys.2019.01514","article-title":"Interleukin-5 in the pathophysiology of severe asthma","volume":"10","author":"Pelaia","year":"2019","journal-title":"Front Physiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.immunol.23.021704.115821","article-title":"Regulation of Th2 differentiation and IL4 locus accessibility","volume":"24","author":"Ansel","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-0716-2740-2_3","article-title":"Early development of innate lymphoid cells","volume":"2580","author":"Ding","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mj\u00f6sberg","year":"2012","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","article-title":"The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells","volume":"37","author":"Hoyler","year":"2012","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.6040\/j.issn.1673-3770.0.2022.192","article-title":"Research progress on the role and regulatory mechanism of group 2 innate lymphoid cells in chronic rhinosinusitis","volume":"37","author":"Cui","year":"2023","journal-title":"J Otolaryngol Ophthalmol Shandong Univ"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.anai.2020.08.001","article-title":"Group 2 innate lymphoid cells in nasal polyposis","volume":"126","author":"Stevens","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jaci.2008.02.018","article-title":"T-cell regulation in chronic paranasal sinus disease","volume":"121","author":"Van Bruaene","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.6040\/j.issn.1673-3770.0.2022.258","article-title":"Research progress on the role of TH2 cytokines in type2 chronic rhinosinusitis with nasal polyps","volume":"37","author":"Zhu","year":"2023","journal-title":"J Otolaryngol Ophthalmol Shandong Univ"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00404-023-07074-w","article-title":"Th2\/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery","volume":"308","author":"Pochert","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3760\/cma.j.cn115330-20240131-00073","article-title":"Progress of multi-omics technology in precision treatment of chronic rhinosinusitis","volume":"59","author":"Hao","year":"2024","journal-title":"Chin J Otorhinolaryngol Head Neck Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41423-019-0210-8","article-title":"Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses","volume":"16","author":"Gurram","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1002\/eji.201242433","article-title":"STAT6-dependent and -independent mechanisms in Th2 polarization","volume":"42","author":"Maier","year":"2012","journal-title":"Eur J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","article-title":"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation","volume":"40","author":"Halim","year":"2014","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nm1332","article-title":"IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis","volume":"12","author":"Fichtner-Feigl","year":"2006","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00011-015-0806-0","article-title":"Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis","volume":"64","author":"Huang","year":"2015","journal-title":"Inflamm Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","article-title":"Commentary: IL-4 and IL-13 receptors and signaling","volume":"75","author":"McCormick","year":"2015","journal-title":"Cytokine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00403-019-01972-3","article-title":"The IL-4\/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets","volume":"312","author":"Nguyen","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"eabd2712","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1 pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci Adv"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1084\/jem.20170051","article-title":"ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control","volume":"214","author":"Schwartz","year":"2017","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"108330","DOI":"10.1016\/j.intimp.2021.108330","article-title":"ILC2s induce adaptive Th2-type immunity in different stages of tuberculosis through the Notch-GATA3 pathway","volume":"101","author":"Li","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/imm.13755","article-title":"PD-1: a critical player and target for immune normalization","volume":"172","author":"Liu","year":"2024","journal-title":"Immunology"},{"key":"B45","first-page":"162","article-title":"An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis","volume":"43","author":"Zhang","year":"2005","journal-title":"Rhinology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.2500\/ajra.2011.25.3727","article-title":"Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model","volume":"25","author":"Kim","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jaci.2017.05.004","article-title":"The IL-33\/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D","volume":"141","author":"Teufelberger","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jaci.2012.05.052","article-title":"Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-\u03b3 and IL-4","volume":"130","author":"Soyka","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaci.2015.01.043","article-title":"Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease","volume":"136","author":"Pothoven","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/cea.13539","article-title":"Key role of the epithelium in chronic upper airways diseases","volume":"50","author":"Gohy","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"B51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/19458924231154061","article-title":"New concepts in barrier dysfunction in CRSwNP and emerging roles of tezepelumab and dupilumab","volume":"37","author":"Chiang","year":"2023","journal-title":"Am J Rhinol Allergy"},{"key":"B52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jaci.2014.05.049","article-title":"Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation","volume":"134","author":"Georas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1177\/1945892419868588","article-title":"Contribution of epithelial cell dysfunction to the pathogenesis of chronic rhinosinusitis with nasal polyps","volume":"33","author":"Wynne","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/alr.21298","article-title":"Interleukin-4 and interleukin-13 compromise the sinonasal epithelial barrier and perturb intercellular junction protein expression","volume":"4","author":"Wise","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"a028241","DOI":"10.1101\/cshperspect.a028241","article-title":"Cilia and mucociliary clearance","volume":"9","author":"Bustamante-Marin","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"L231","DOI":"10.1152\/ajplung.90209.2008","article-title":"Ciliated epithelial cell lifespan in the mouse trachea and lung","volume":"295","author":"Rawlins","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1083\/jcb.201304099","article-title":"Big steps toward understanding dynein","volume":"202","author":"Kikkawa","year":"2013","journal-title":"J Cell Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e24997","DOI":"10.4161\/tisb.24997","article-title":"Barrier function of airway tract epithelium","volume":"1","author":"Ganesan","year":"2013","journal-title":"Tissue Barriers"},{"key":"B59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/cea.12644","article-title":"Role of IFN-\u03b3, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps","volume":"46","author":"Jiao","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1165\/rcmb.2009-0118OC","article-title":"Conditional deletion of dnaic1 in a murine model of primary ciliary dyskinesia causes chronic rhinosinusitis","volume":"43","author":"Ostrowski","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/lary.23586","article-title":"Adenosine increases nasal mucociliary clearance rate in mice through A2A and A2B adenosine receptors","volume":"123","author":"Hua","year":"2013","journal-title":"Laryngoscope"},{"key":"B62","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2500\/ajr.2006.20.2870","article-title":"Altered sinonasal ciliary dynamics in chronic rhinosinusitis","volume":"20","author":"Chen","year":"2006","journal-title":"Am J Rhinol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s004050050158","article-title":"Alterations of nasal mucociliary transport in patients with hypertrophy of the inferior turbinates, deviations of the nasal septum and chronic sinusitis","volume":"256","author":"Pass\u00e0li","year":"1999","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.alit.2017.10.006","article-title":"Barrier dysfunction in the nasal allergy","volume":"67","author":"Fukuoka","year":"2018","journal-title":"Allergol Int"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jaci.2015.10.050","article-title":"Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression","volume":"137","author":"Steelant","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0091-6749(97)70091-5","article-title":"Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps)","volume":"99","author":"Bernstein","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000362246","article-title":"The expression of epithelial intercellular junctional proteins in the sinonasal tissue of subjects with chronic rhinosinusitis: a histopathologic study","volume":"76","author":"Li","year":"2014","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"B68","doi-asserted-by":"publisher","first-page":"572749","DOI":"10.3389\/fcell.2020.572749","article-title":"Interleukin-13 alters tight junction proteins expression thereby compromising barrier function and dampens rhinovirus induced immune responses in nasal epithelium","volume":"8","author":"Huang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.6040\/j.issn.1673-3770.0.2021.583","article-title":"Progress of research regarding the role of the epithelial barrier in chronic rhinosinusitis with nasal polyps","volume":"36","author":"Huang","year":"2022","journal-title":"J Otolaryngol Ophthalmol Shandong Univ"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jaci.2012.03.005","article-title":"Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment","volume":"129","author":"Kagalwalla","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"835888","DOI":"10.3389\/fimmu.2022.835888","article-title":"S100a4\/TCF complex transcription regulation drives epithelial-mesenchymal transition in chronic sinusitis through Wnt\/GSK-3\u03b2\/\u03b2-catenin signaling","volume":"13","author":"Gong","year":"2022","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jaci.2021.04.024","article-title":"DEP-induced ZEB2 promotes nasal polyp formation via epithelial-to-mesenchymal transition","volume":"149","author":"Lee","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/alr.22243","article-title":"Inhibition of arachidonate 15-lipoxygenase reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"9","author":"Yan","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"B75","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaci.2020.06.037","article-title":"Proteomic analysis of nasal mucus samples of healthy patients and patients with chronic rhinosinusitis","volume":"147","author":"Kao","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000497829","article-title":"TGF-\u03b21 induces epithelial-mesenchymal transition of chronic sinusitis with nasal polyps through microRNA-21","volume":"179","author":"Li","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000516847","article-title":"Eosinophils correlate with epithelial-mesenchymal transition in chronic rhinosinusitis with nasal polyps","volume":"84","author":"Wang","year":"2022","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1159\/000524950","article-title":"The role of epithelial-mesenchymal transition in chronic rhinosinusitis","volume":"183","author":"Xia","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molimm.2024.09.004","article-title":"Piezo1 regulates TGF-\u03b21 induced epithelial-mesenchymal transition in chronic rhinosinusitis with nasal polyps","volume":"175","author":"Shu","year":"2024","journal-title":"Mol Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"242","DOI":"10.14639\/0392-100X-N2717","article-title":"TIM-3-driven macrophage polarisation is associated to recalcitrant chronic rhinosinusitis with nasal polyps","volume":"44","author":"Jiang","year":"2024","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"B81","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"B82","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/all.14571","article-title":"Hypoxia-induced factor-1\u03b1 induces NLRP3 expression by M1 macrophages in noneosinophilic chronic rhinosinusitis with nasal polyps","volume":"76","author":"Zhong","year":"2021","journal-title":"Allergy"},{"key":"B84","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00011-024-01855-y","article-title":"Deficiency of INPP4A promotes M2 macrophage polarization in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"73","author":"Xu","year":"2024","journal-title":"Inflamm Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1047930","DOI":"10.3389\/fimmu.2022.1047930","article-title":"M2 macrophage-related gene signature in chronic rhinosinusitis with nasal polyps","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"928134","DOI":"10.3389\/fimmu.2022.928134","article-title":"Advances in the regulation of macrophage polarization by mesenchymal stem cells and implications for ALI\/ARDS treatment","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1398-9995.2010.02498.x","article-title":"Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis","volume":"66","author":"Krysko","year":"2011","journal-title":"Allergy"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/alr.22430","article-title":"Hemokinin-1 stimulates C-C motif chemokine ligand 24 production in macrophages to enhance eosinophilic inflammation in nasal polyps","volume":"9","author":"Deng","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.1002\/iid3.781","article-title":"Loss of SENP3 mediated the formation of nasal polyps in nasal mucosal inflammation by increasing alternative activated macrophage","volume":"11","author":"Bao","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"B90","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/path.4133","article-title":"Macrophage plasticity and polarization in tissue repair and remodelling","volume":"229","author":"Mantovani","year":"2013","journal-title":"J Pathol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/CS20210778","article-title":"Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage\/WNT\/ERK signaling pathway","volume":"136","author":"Liang","year":"2022","journal-title":"Clin Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"947983","DOI":"10.3389\/fimmu.2022.947983","article-title":"IL-10 family cytokines in chronic rhinosinusitis with nasal polyps: from experiments to the clinic","volume":"13","author":"Xuan","year":"2022","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","article-title":"Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages","volume":"356","author":"Ip","year":"2017","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/alr.22218","article-title":"Deficiency in interleukin-10 production by M2 macrophages in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"8","author":"Wang","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"112236","DOI":"10.1016\/j.intimp.2024.112236","article-title":"Macrophages in CRSwNP: do they deserve more attention?","volume":"134","author":"Fan","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12931-023-02526-y","article-title":"Macrophage migration inhibitory factor exacerbates asthmatic airway remodeling via dynamin-related protein 1-mediated autophagy activation","volume":"24","author":"Liu","year":"2023","journal-title":"Respir Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4193\/Rhin23.412","article-title":"Elevated MIF identified by multiple cytokine analyses facilitates macrophage M2 polarization contributing to postoperative recurrence in chronic rhinosinusitis with nasal polyps","volume":"62","author":"Xie","year":"2024","journal-title":"Rhinol J"},{"key":"B98","doi-asserted-by":"publisher","first-page":"107211","DOI":"10.1016\/j.intimp.2020.107211","article-title":"Prediction of sublingual immunotherapy efficacy in allergic rhinitis by serum metabolomics analysis","volume":"90","author":"Xie","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaci.2017.10.038","article-title":"Autophagy deficiency in myeloid cells exacerbates eosinophilic inflammation in chronic rhinosinusitis","volume":"141","author":"Choi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jhep.2015.08.019","article-title":"Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1\u03b2","volume":"64","author":"Ilyas","year":"2016","journal-title":"J Hepatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"110309","DOI":"10.1016\/j.celrep.2022.110309","article-title":"Macrophage IL-1\u03b2 promotes arteriogenesis by autocrine STAT3- and NF-\u03baB-mediated transcription of pro-angiogenic VEGF-A","volume":"38","author":"Mantsounga","year":"2022","journal-title":"Cell Rep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1164\/rccm.200905-0740OC","article-title":"Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis","volume":"180","author":"Lee","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaci.2010.02.023","article-title":"Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis","volume":"125","author":"Li","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1081-1206(10)62222-3","article-title":"A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders","volume":"87","author":"Schubert","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11882-019-0853-7","article-title":"The role of Staphylococcus aureus in patients with chronic sinusitis and nasal polyposis","volume":"19","author":"Vickery","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13601-020-00348-5","article-title":"Unravelling the expression of interleukin-9 in chronic rhinosinusitis: a possible role for Staphylococcus aureus","volume":"10","author":"Delemarre","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"B108","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1017\/S0022215117001335","article-title":"Role of local allergic inflammation and Staphylococcus aureus enterotoxins in Chinese patients with chronic rhinosinusitis with nasal polyps","volume":"131","author":"Cheng","year":"2017","journal-title":"J Laryngol Otol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00405-018-4931-6","article-title":"The microbiology of chronic rhinosinusitis with and without nasal polyps","volume":"275","author":"Wei","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4168\/aair.2020.12.4.653","article-title":"Altered mitochondrial functions and morphologies in epithelial cells are associated with pathogenesis of chronic rhinosinusitis with nasal polyps","volume":"12","author":"Yoon","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4193\/Rhin23.415","article-title":"EPOS2020\/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP","volume":"62","author":"Fokkens","year":"2024","journal-title":"Rhinol J"},{"key":"B113","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41573-023-00750-1","article-title":"Type 2 chronic inflammatory diseases: targets, therapies and unmet needs","volume":"22","author":"Kolkhir","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"B114","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11882-023-01114-w","article-title":"Type 2 biomarkers for the indication and response to biologics in CRSwNP","volume":"23","author":"Guo","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"B115","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B116","doi-asserted-by":"publisher","first-page":"E1770","DOI":"10.1002\/lary.29230","article-title":"The effect of dupilumab on intractable chronic rhinosinusitis with nasal polyps in Japan","volume":"131","author":"Fujieda","year":"2021","journal-title":"Laryngoscope"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.jaip.2022.02.034","article-title":"Comparison of different biologics for treating chronic rhinosinusitis with nasal polyps: a network analysis","volume":"10","author":"Cai","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/alr.22780","article-title":"Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"11","author":"Hopkins","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaip.2021.09.037","article-title":"Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps","volume":"10","author":"Mullol","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B121","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/19458924221132065","article-title":"Circulating T cell subsets and ILC2s are altered in patients with chronic rhinosinusitis with nasal polyps after dupilumab treatment","volume":"37","author":"Matsuyama","year":"2023","journal-title":"Am J Rhinol Allergy"},{"key":"B122","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/all.13685","article-title":"Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis","volume":"74","author":"Jonstam","year":"2019","journal-title":"Allergy"},{"key":"B123","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40257-020-00527-x","article-title":"Dupilumab provides favorable safety and sustained efficacy for up to 3 years in an open-label study of adults with moderate-to-severe atopic dermatitis","volume":"21","author":"Beck","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.medcli.2023.04.035","article-title":"Mepolizumab to treat eosinophilic granulomatosis with polyangiitis [Mepolizumab en la granulomatosis eosinof\u00edlica con poliangitis]","volume":"162","author":"Callejas Rubio","year":"2024","journal-title":"Med Cl\u00edn"},{"key":"B127","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.anai.2021.01.010","article-title":"Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis","volume":"126","author":"Cavaliere","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/jpm12081304","article-title":"Mepolizumab improves outcomes of chronic rhinosinusitis with nasal polyps in severe asthmatic patients: a multicentric real-life study","volume":"12","author":"Gallo","year":"2022","journal-title":"J Pers Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18176\/jiaci.0812","article-title":"Improvement in olfaction in patients with CRSwNP and severe asthma taking anti-IgE and anti-IL-5 biologics: a real-life study","volume":"33","author":"Barroso","year":"2022","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00405-024-09027-8","article-title":"Effects of mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study","volume":"282","author":"Orlando","year":"2025","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/19458924221147770","article-title":"B lineage cells and IgE in allergic rhinitis and CRSwNP and the role of omalizumab treatment","volume":"37","author":"Bai","year":"2023","journal-title":"Am J Rhinol Allergy"},{"key":"B134","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/biomedicines9070787","article-title":"Omalizumab restores response to corticosteroids in patients with eosinophilic chronic rhinosinusitis and severe asthma","volume":"9","author":"Kobayashi","year":"2021","journal-title":"Biomedicines"},{"key":"B136","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1111\/all.15008","article-title":"Potential cancer risk with omalizumab? A disproportionality analysis of the WHO\u2019s VigiBase pharmacovigilance database","volume":"76","author":"Mota","year":"2021","journal-title":"Allergy"},{"key":"B137","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jaci.2020.01.020","article-title":"Biologics for chronic rhinosinusitis with nasal polyps","volume":"145","author":"Bachert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejim.2018.01.026","article-title":"Factors reducing omalizumab response in severe asthma","volume":"52","author":"Sposato","year":"2018","journal-title":"Eur J Intern Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.jaci.2021.03.016","article-title":"What is the contribution of IgE to nasal polyposis?","volume":"147","author":"Bachert","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12016-015-8490-y","article-title":"Off-label uses of omalizumab","volume":"50","author":"El-Qutob","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","article-title":"Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma","volume":"24","author":"Gauvreau","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/all.15986","article-title":"Tezepelumab in patients with allergic and eosinophilic asthma","volume":"79","author":"Caminati","year":"2024","journal-title":"Allergy"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","article-title":"Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps","volume":"392","author":"Lipworth","year":"2025","journal-title":"N Engl J Med"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e70051","DOI":"10.1002\/clt2.70051","article-title":"Benralizumab and the integrated management of co-morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps","volume":"15","author":"Mullol","year":"2025","journal-title":"Clin Transl Allergy"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bjd.19574","article-title":"Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)","volume":"184","author":"Wollenberg","year":"2021","journal-title":"Br J Dermatol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJMoa2206714","article-title":"Two phase 3 trials of lebrikizumab for moderate-to-severe atopic dermatitis","volume":"388","author":"Silverberg","year":"2023","journal-title":"N Engl J Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jaip.2022.03.002","article-title":"Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era","volume":"10","author":"Mullol","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/all.16499","article-title":"Efficacy and safety of biologics for chronic rhinosinusitis with nasal polyps: a meta-analysis of real-world evidence","volume":"80","author":"Cai","year":"2025","journal-title":"Allergy"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jaci.2024.10.032","article-title":"Analysis of human neutrophils from nasal polyps by single-cell RNA sequencing reveals roles of neutrophils in chronic rhinosinusitis","volume":"155","author":"Iwasaki","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/imr.13380","article-title":"Therapeutic monoclonal antibodies in allergy: targeting IgE, cytokine, and alarmin pathways","volume":"328","author":"Eggel","year":"2024","journal-title":"Immunol Rev"},{"key":"B155","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1002\/lary.31305","article-title":"Real-world adverse events after type 2 biologic use in chronic rhinosinusitis with nasal polyps","volume":"134","author":"Dorling","year":"2024","journal-title":"Laryngoscope"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/lary.29992","article-title":"Dupilumab adverse events in nasal polyp treatment: analysis of FDA adverse event reporting system","volume":"132","author":"Swisher","year":"2022","journal-title":"Laryngoscope"},{"key":"B157","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.intimp.2019.04.020","article-title":"Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization","volume":"72","author":"Cao","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/all.16519","article-title":"Chinese position paper on biologic therapy for chronic rhinosinusitis with nasal polyps","volume":"80","author":"Xian","year":"2025","journal-title":"Allergy"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jaci.2025.03.011","article-title":"Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps","volume":"155","author":"Kratchmarov","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/alr.23246","article-title":"Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP)","volume":"14","author":"Garvey","year":"2024","journal-title":"Int Forum Allergy Rhinol"}],"updated-by":[{"DOI":"10.3389\/falgy.2025.1679519","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000}}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1599797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:57:41Z","timestamp":1756810661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1599797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":161,"alternative-id":["10.3389\/falgy.2025.1599797"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1599797","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"article-number":"1599797"}}